UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
||||
FORM
8-K
|
||||
CURRENT
REPORT
|
||||
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of
1934
|
Date
of Report (Date of earliest event reported)
|
March 19,
2009
|
NexMed,
Inc.
|
||||
(Exact
name of registrant as specified in its
charter)
|
Nevada
|
0-22245
|
87-0449967
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
89
Twin Rivers Drive, East Windsor, New Jersey
|
08520
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code (609)
371-8123
|
(Former
name or former address, if changed since last
report.)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|||
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|||
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|||
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13a-4(c))
|
NEXMED,
INC.
|
|||
By:
|
/s/
Mark Westgate
|
||
Name:
|
Mark
Westgate
|
||
Title:
|
Vice
President and
Chief
Financial Officer
|